These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8010976)

  • 1. Inhibition of calmodulin-dependent myosin light-chain kinase by growth-hormone-releasing factor and vasoactive intestinal peptide.
    Shiraga H; Stallwood D; Ebadi M; Pfeiffer R; Landers D; Paul S
    Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):901-5. PubMed ID: 8010976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
    Laburthe M; Couvineau A; Rouyer-Fessard C
    Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
    Waelbroeck M; Robberecht P; Coy DH; Camus JC; De Neef P; Christophe J
    Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation.
    Moretti C; Bagnato A; Solan N; Frajese G; Catt KJ
    Endocrinology; 1990 Nov; 127(5):2117-26. PubMed ID: 2171907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide: role of calmodulin and catalytic antibodies.
    Bolin DR
    Neurochem Int; 1993 Sep; 23(3):221-7. PubMed ID: 8220168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenocorticotropin, vasoactive intestinal polypeptide, growth hormone-releasing factor, and dynorphin compete for common receptors in brain and adrenal.
    Li ZG; Queen G; LaBella FS
    Endocrinology; 1990 Mar; 126(3):1327-33. PubMed ID: 1968378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
    Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of calmodulin-activated smooth-muscle myosin light-chain kinase by calmodulin-binding peptides and fluorescent (phosphodiesterase-activating) calmodulin derivatives.
    Török K; Cowley DJ; Brandmeier BD; Howell S; Aitken A; Trentham DR
    Biochemistry; 1998 Apr; 37(17):6188-98. PubMed ID: 9558358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identity of a membrane-bound vasoactive intestinal peptide-binding protein with calmodulin.
    Stallwood D; Brugger CH; Baggenstoss BA; Stemmer PM; Shiraga H; Landers DF; Paul S
    J Biol Chem; 1992 Sep; 267(27):19617-21. PubMed ID: 1527080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S; Rattan S
    J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of growth hormone release by vasoactive intestinal peptide and peptide PHI in rat anterior pituitary reaggregates. Permissive action of a glucocorticoid and inhibition by thyrotropin-releasing hormone.
    Denef C; Schramme C; Baes M
    Neuroendocrinology; 1985 Jan; 40(1):88-91. PubMed ID: 3918279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro.
    Dufes C; Alleaume C; Montoni A; Olivier JC; Muller JM
    J Mol Neurosci; 2003; 21(2):91-102. PubMed ID: 14593209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of calmodulin in the first calcium-binding pocket by myosin light chain kinase.
    Davis HW; Crimmins DL; Thoma RS; Garcia JG
    Arch Biochem Biophys; 1996 Aug; 332(1):101-9. PubMed ID: 8806714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the insulinotropic activity of glucagon-superfamily peptides in rat pancreas perfusion.
    Suzuki S; Kawai K; Ohashi S; Watanabe Y; Yamashita K
    Horm Metab Res; 1992 Oct; 24(10):458-61. PubMed ID: 1464409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide (VIP) as transmitter of inhibitory motor neurons of the gut: evidence from the use of selective VIP antagonists and VIP antiserum.
    Grider JR; Rivier JR
    J Pharmacol Exp Ther; 1990 May; 253(2):738-42. PubMed ID: 2110976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
    Zhou ZC; Gardner JD; Jensen RT
    Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and secretion of vasoactive intestinal peptide by rat fetal cerebral cortical and hypothalamic cells in culture.
    Lorenzo MJ; Sánchez-Franco F; de los Frailes MT; Reichlin S; Férnandez G; Cacicedo L
    Endocrinology; 1989 Oct; 125(4):1983-90. PubMed ID: 2507286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
    Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
    Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MS-282a and MS-282b, new inhibitors of calmodulin-activated myosin light chain kinase from Streptomyces tauricus ATCC 27470.
    Nakanishi S; Kita K; Uosaki Y; Yoshida M; Saitoh Y; Mihara A; Kawamoto I; Matsuda Y
    J Antibiot (Tokyo); 1994 Aug; 47(8):855-61. PubMed ID: 7928670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.